Keigi Fujiwara Selected Research

Keigi Fujiwara Research Topics

Disease

11	Inflammation (Inflammations) 12/2021 - 09/2010
9	Atherosclerosis 01/2019 - 05/2011
4	Neoplasms (Cancer) 11/2021 - 01/2018
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 10/2012
3	Atherosclerotic Plaque (Atheroma) 01/2018 - 03/2013
2	Bites and Stings (Sting) 01/2020 - 01/2017
2	Hypertension (High Blood Pressure) 03/2016 - 10/2012
2	Myocardial Infarction 10/2012 - 02/2012
1	Vascular Diseases (Vascular Disease) 12/2021
1	Coronary Artery Disease (Coronary Atherosclerosis) 11/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 11/2021
1	Chromosome Aberrations (Chromosome Abnormalities) 09/2020
1	Rupture 01/2020
1	Genomic Instability 09/2019
1	Cardiac Arrhythmias (Arrythmia) 01/2017
1	Epilepsy (Aura) 01/2017
1	Obesity 01/2017
1	Diabetes Mellitus 01/2013
1	Reperfusion Injury 10/2012
1	Type 2 Diabetes Mellitus (MODY) 10/2012
1	Heart Failure 10/2012
1	Infarction (Infarctions) 01/2012
1	Fibrosis (Cirrhosis) 11/2011

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2012
4	Phosphotransferases (Kinase)IBA 01/2020 - 03/2015
3	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2021 - 01/2012
3	Pharmaceutical PreparationsIBA 01/2019 - 10/2012
2	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2021 - 01/2018
2	Interferon Regulatory Factor-3 (Interferon Regulatory Factor 3)IBA 01/2020 - 01/2017
2	InterferonsIBA 01/2020 - 01/2017
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2014 - 07/2014
2	Ligases (Synthetase)IBA 02/2013 - 02/2012
1	Focal Adhesion Protein-Tyrosine KinasesIBA 12/2021
1	Adenosine Triphosphate (ATP)IBA 11/2021
1	NAD (NADH)IBA 11/2021
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 11/2021
1	CarbonIBA 09/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2020
1	Mitochondrial DNA (mtDNA)IBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	Angiotensin IIIBA 01/2020
1	IonsIBA 09/2019
1	Guanylate KinasesIBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Cisplatin (Platino)FDA LinkGeneric 01/2018
1	InflammasomesIBA 01/2017
1	Nonesterified Fatty Acids (NEFA)IBA 01/2017
1	Potassium Channels (Potassium Channel)IBA 01/2017
1	Palmitic Acid (Hexadecanoic Acid)IBA 01/2017
1	Nitric Oxide Synthase (NO Synthase)IBA 03/2016
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2016
1	LipidsIBA 03/2015
1	Antimalarials (Antimalarial Agents)IBA 10/2014
1	RNA (Ribonucleic Acid)IBA 09/2014
1	LDL Receptors (LDL Receptor)IBA 07/2014
1	CholesterolIBA 07/2014
1	Peptide Hydrolases (Proteases)FDA Link 03/2013
1	SUMO-1 Protein (SUMO Protein)IBA 03/2013
1	EnzymesIBA 03/2013
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 02/2013
1	KetonesIBA 01/2013
1	EkoIBA 01/2013
1	90-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 90 kDa)IBA 01/2013
1	Mitogen-Activated Protein Kinase 7IBA 01/2013
1	Apolipoproteins E (ApoE)IBA 01/2013
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 01/2013
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 10/2012
1	Lipoproteins (Lipoprotein)IBA 10/2012
1	Glucagon-Like Peptide 1 (GLP 1)IBA 10/2012
1	IncretinsIBA 10/2012
1	Dipeptidyl-Peptidase IV InhibitorsIBA 10/2012
1	UbiquitinIBA 02/2012
1	ThioredoxinsIBA 02/2012
1	Kruppel-Like Transcription Factors (Kruppel-Like Factors)IBA 02/2012
1	HDL CholesterolIBA 01/2012
1	Isoproterenol (Isoprenaline)FDA LinkGeneric 11/2011
1	Protein Kinase CIBA 05/2011
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2010

Therapy/Procedure

2	Therapeutics 11/2021 - 01/2018
1	Highly Active Antiretroviral Therapy (HAART) 01/2019
1	Radiotherapy 01/2018
1	Ligation 01/2018